• Kent Griffin

Kent Griffin

Board of Advisors

Kent Griffin serves as the Managing Director of PHICAS Investors, providing investment and capital strategy advisory services to public and private companies.  Mr. Griffin serves a member of the Board of Directors of TIER REIT (NYSE: TIER) a Dallas-based real estate investment trust which invests in premier commercial office properties in select, high-growth markets.

Mr Griffin served as the President and Chief Operating Officer of BioMed Realty Trust (NYSE:BMR), a real estate investment trust exclusively focused on the life science industry.  BioMed Realty, with over $7 billion of investments across the United State and the United Kingdom, was acquired by Blackstone in 2016.  Mr. Griffin also served on the investment committee and the advisory board for BioMed Ventures, which provides advisory services and structured investments for growth companies in the life science industry – including the drug discovery, drug development, diagnostics, tools and medical device sectors.  

Previously, Mr. Griffin held a variety of investment banking positions with JPMorgan and Raymond James & Associates.  Prior to that, Mr. Griffin was part of the real estate service group for Arthur Andersen LLP, where he was responsible for a range of advisory and audit services as a Certified Public Accountant.

Mr. Griffin received a MBA from the University of North Carolina and a BS in Business and Accountancy from Wake Forest University.